TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 308 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2020. The put-call ratio across all filers is 1.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $919,119 | +79.7% | 59,413 | +82.4% | 0.00% | +100.0% |
| Q2 2023 | $511,580 | -1.2% | 32,564 | +3.6% | 0.00% | 0.0% |
| Q1 2023 | $517,884 | -9.1% | 31,425 | -14.0% | 0.00% | -33.3% |
| Q4 2022 | $569,884 | +175.3% | 36,531 | +128.9% | 0.00% | +200.0% |
| Q3 2022 | $207,000 | +19.0% | 15,958 | +28.6% | 0.00% | 0.0% |
| Q2 2022 | $174,000 | +43.8% | 12,405 | +47.1% | 0.00% | 0.0% |
| Q1 2022 | $121,000 | -43.2% | 8,434 | -45.9% | 0.00% | 0.0% |
| Q4 2021 | $213,000 | +69.0% | 15,601 | +102.1% | 0.00% | 0.0% |
| Q3 2021 | $126,000 | -14.9% | 7,720 | -12.3% | 0.00% | 0.0% |
| Q2 2021 | $148,000 | 0.0% | 8,804 | +8.6% | 0.00% | -50.0% |
| Q1 2021 | $148,000 | +33.3% | 8,107 | +32.4% | 0.00% | +100.0% |
| Q4 2020 | $111,000 | +50.0% | 6,122 | +45.6% | 0.00% | 0.0% |
| Q3 2020 | $74,000 | +37.0% | 4,204 | +37.7% | 0.00% | 0.0% |
| Q2 2020 | $54,000 | – | 3,052 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Adelphi Capital LLP | 8,958,784 | $176,757,000 | 33.75% |
| Ovata Capital Management Ltd | 879,800 | $17,557,092,000 | 13.04% |
| Paulson & Co. | 13,244,711 | $261,318,000 | 5.64% |
| Glenview Capital Management | 30,582,721 | $603,397,000 | 5.28% |
| MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC | 718,028 | $14,167,000 | 4.85% |
| Velanne Asset Management Ltd | 302,694 | $5,972,000 | 3.52% |
| Blackcrane Capital, LLC | 172,708 | $3,408,000 | 2.72% |
| Melqart Asset Management (UK) Ltd | 1,557,000 | $30,720,000 | 2.57% |
| GMT CAPITAL CORP | 3,345,976 | $66,016,000 | 2.55% |
| REDWOOD CAPITAL MANAGEMENT, LLC | 827,955 | $16,336,000 | 2.24% |